These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7736452)

  • 41. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
    Igarashi A; Konno H; Tanaka T; Nakamura S; Sadzuka Y; Hirano T; Fujise Y
    Toxicol Lett; 2003 Nov; 145(2):133-41. PubMed ID: 14581165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Improved argon laser photodynamic therapy for superficial bladder tumor--experimental research and clinical analysis].
    Guo YC
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):75-7. PubMed ID: 2142071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
    Waldow SM; Henderson BW; Dougherty TJ
    Lasers Surg Med; 1987; 7(1):12-22. PubMed ID: 2952850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Photodynamic therapy for gastric cancer].
    Mimura S; Narahara H; Uehara H; Otani T; Okuda S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):41-6. PubMed ID: 8546468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Porfimer sodium (Photofrin-II)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1271-8. PubMed ID: 7661580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
    Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
    Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II.
    Williams RD; Runge TC
    Photochem Photobiol; 1987 Nov; 46(5):733-7. PubMed ID: 2964661
    [No Abstract]   [Full Text] [Related]  

  • 49. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
    Winther JB
    Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
    Gibson SL; van der Meid KR; Murant RS; Hilf R
    Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
    Margaron P; Madarnas P; Quellet R; Van Lier JE
    Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
    Cecic I; Stott B; Korbelik M
    Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
    Chang CJ; Yu JS; Wei FC
    Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.
    Henderson BW; Busch TM; Vaughan LA; Frawley NP; Babich D; Sosa TA; Zollo JD; Dee AS; Cooper MT; Bellnier DA; Greco WR; Oseroff AR
    Cancer Res; 2000 Feb; 60(3):525-9. PubMed ID: 10676629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variable light-dose effect on photodynamic therapy for laryngeal papillomas.
    Abramson AL; Shikowitz MJ; Mullooly VM; Steinberg BM; Hyman RB
    Arch Otolaryngol Head Neck Surg; 1994 Aug; 120(8):852-5. PubMed ID: 8049048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Photodynamic therapy of superficial bladder tumors].
    Misaki T; Hisazumi H; Hirata A; Kunimi K; Yamamoto H; Amano T; Kumaki O; Koshida K; Nishino A; Nakazima K
    Hinyokika Kiyo; 1986 Dec; 32(12):1941-8. PubMed ID: 3825831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma.
    Nonaka T; Nanashima A; Nonaka M; Uehara M; Isomoto H; Nonaka Y; Nagayasu T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):592-600. PubMed ID: 21360081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
    Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematoporphyrin photodynamic therapy for transitional cell carcinoma of the bladder--an update.
    Benson RC
    Adv Exp Med Biol; 1985; 193():3-12. PubMed ID: 4096299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.